Regulation of XAF1 expression in human colon cancer cell by interferon β: Activation by the transcription regulator STAT1

Cancer Letters

Volumn 260, Issue 1-2, 2008, Pages 62-71

  Sun, Yunwei ^a,b   Qiao, Liang ^b   Xia, Harry Hua Xiang ^b   Lin, Marie C M ^b   Zou, Bing ^b   Yuan, Yaozong ^a   Zhu, Senlin ^b   Gu, Qing ^b   Cheung, Ting Kin ^b   Kung, Hsiang Fu ^c   Yuen, Man Fung ^b   Chan, Annie OO ^b   Wong, Benjamin C Y ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Colon cancer; IFN ; Stat1; XAF1

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; CYCLOHEXIMIDE; DACTINOMYCIN; RNA; ROTTLERIN; SMALL INTERFERING RNA; STAT1 PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; RESPONSE ELEMENTS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 38149058329     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.014     Document Type: Article

References (40)

1. Caraglia M., Marra M., Pelaia G., Maselli R., Caputi M., Marsico S.A., and Abbruzzese A. Alpha-interferon and its effects on signal transduction pathways. J. Cell. Physiol. 202 (2005) 323-335
2. Pestka S. Interferon from 1981 to 1986. Methods Enzymol. 119 (1986) 3-14
3. Pestka S. Advances in cancer: interferon-achievements and potential. N J Med. 84 (1987) 51-56
4. Pestka S., Langer J.A., Zoon K.C., and Samuel C.E. Interferons and their actions. Annu. Rev. Biochem. 56 (1987) 727-777
5. Sangfelt O., Erickson S., Castro J., Heiden T., Einhorn S., and Grander D. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ. 8 (1997) 343-352
6. Cai J., and Jones D.P. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J. Biol. Chem. 273 (1998) 11401-11404
7. Dai C., and Krantz S.B. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93 (1999) 3309-3316
8. Thyrell L., Erickson S., Zhivotovsky B., Pokrovskaja K., Sangfelt O., Castro J., Einhorn S., and Grander D. Mechanisms of Interferon-alpha induced apoptosis in malignant cells. Oncogene 21 (2002) 1251-1262
9. LaCasse E.C., Baird S., Korneluk R.G., and MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17 (1998) 3247-3259
10. Holcik M., Gibson H., and Korneluk R.G. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6 (2001) 253-261
11. Fong W.G., Liston P., Rajcan-Separovic E., St J.M., Craig C., and Korneluk R.G. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70 (2000) 113-122
12. Liston P., Fong W.G., Kelly N.L., Toji S., Miyazaki T., Conte D., Tamai K., Craig C.G., McBurney M.W., and Korneluk R.G. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat. Cell Biol. 3 (2001) 128-133
13. Byun D.S., Cho K., Ryu B.K., Lee M.G., Kang M.J., Kim H.R., and Chi S.G. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res. 63 (2003) 7068-7075
14. Leaman D.W., Chawla-Sarkar M., Vyas K., Reheman M., Tamai K., Toji S., and Borden E.C. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J. Biol. Chem. 277 (2002) 28504-28511
15. Leaman D.W., Chawla-Sarkar M., Jacobs B., Vyas K., Sun Y., Ozdemir A., Yi T., Williams B.R., and Borden E.C. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J. Interferon Cytokine Res. 23 (2003) 745-756
16. Martensen P.M., and Justesen J. Small ISGs coming forward. J. Interferon Cytokine Res. 24 (2004) 1-19
17. Darnell Jr. J.E. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18 (1998) 549-554
18. Darnell Jr. J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
19. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25 (2000) 496-502
20. Levy D.E., and Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3 (2002) 651-662
21. Platanias L.C., and Fish E.N. Signaling pathways activated by interferons. Exp. Hematol. 27 (1999) 1583-1592
22. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
23. Lesinski G.B., Anghelina M., Zimmerer J., Bakalakos T., Badgwell B., Parihar R., Hu Y., Becknell B., Abood G., Chaudhury A.R., Magro C., Durbin J., and Carson III W.E. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J. Clin. Invest. 112 (2003) 170-180
24. Zou B., Chim C.S., Zeng H., Leung S.Y., Yang Y., Tu S.P., Lim M.C.M., Wang J.D., He H., Jiang S.H., Sun Y.W., Yu L.F., Yuen S.T., Kung H.F., and Wong B.C.Y. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 131 (2006) 1835-1843
25. Wong B.C., Jiang X.H., Lin M.C., Tu S.P., Cui J.T., Jiang S.H., Wong W.M., Yuen M.F., Lam S.K., and Kung H.F. Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase. Gastroenterology 126 (2004) 136-147
26. Moreno C.S., Beresford G.W., Louis-Plence P., Morris A.C., and Boss J.M. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10 (1999) 143-151
27. Wang J.D., Peng Y., Sun Y.W., He H., Zhu S., An X., Li M., Lin M.C., Zou B., Xia H.H., Jiang B., Chan A.O., Yuen M.F., Kung H.F., and Wong B.C. All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology 130 (2006) 747-758
28. Wang J.D., Peng Y., Sun Y.W., He H., Zhu S.L., An X.M., Li M., Lin M.C., Zou B., Xia H.H., Jiang B., Chan A.O., Yuen M.F., Kung H.F., and Wong B.C.Y. All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology 130 (2006) 747-758
29. Platanias L.C. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol. Ther. 98 (2003) 129-142
30. Uddin S., Chamdin A., and Platanias L.C. Interaction of the transcriptional activator Stat-2 with the type I interferon receptor. J. Biol. Chem. 270 (1995) 24627-24630
31. Li Y., Srivastava K.K., and Platanias L.C. Mechanisms of type I interferon signaling in normal and malignant cells. Arch. Immunol. Ther. Exp. (Warsz.) 52 (2004) 156-163
32. Ramana C.V., Chatterjee-Kishore M., Nguyen H., and Stark G.R. Complex roles of Stat1 in regulating gene expression. Oncogene 19 (2000) 2619-2627
33. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19 (2001) 623-655
34. Prejean C., and Colamonici O.R. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling. Semin. Cancer Biol. 10 (2000) 83-92
35. Parmar S., and Platanias L.C. Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15 (2003) 431-439
36. Mogensen K.E., Lewerenz M., Reboul J., Lutfalla G., and Uze G. The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 19 (1999) 1069-1098
37. Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A.G., Barbieri G., Witthuhn B.A., and Schindler C. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366 (1993) 129-135
38. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
39. Kaur S., Parmar S., Smith J., Katsoulidis E., Li Y., Sassano A., Majchrzak B., Uddin S., Tallman M.S., Fish E.N., and Platanias L.C. Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Exp. Hematol. 33 (2005) 550-557
40. Uddin S., Sassano A., Deb D.K., Verma A., Majchrzak B., Rahman A., Malik A.B., Fish E.N., and Platanias L.C. Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem. 277 (2002) 14408-14416